Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer - Summary - MDSpire
To correct inaccuracies in the published article regarding surgical treatment and prognosis in patients with intestinal metastases from advanced epithelial ovarian cancer.
Approach:
Correction of Table 1: Inaccuracies in the FIGO Stages for Stages IA and IIB were corrected, and the term 'Other' was reformatted to 'IIIA and IIIB'.
Amendment in Materials and Methods: The term '3orksycles' was corrected to '3–4 cycles' in the Patients section.
Patient Preparation: All patients initiated a liquid diet three days before surgery for bowel preparation, along with oral laxatives administered one day prior.
Neoadjuvant Chemotherapy Guidelines: Current guidelines recommend neoadjuvant chemotherapy for patients unable to undergo immediate surgery due to extensive disease and high perioperative risk.
Chemotherapy Regimens: NACT typically includes platinum-based combination chemotherapy (paclitaxel plus carboplatin) for three to four cycles; PDS patients receive postoperative chemotherapy for six to eight cycles.
Key Findings:
Corrections made to FIGO Stages in Table 1.
Terminology and formatting errors in Table 1 were rectified.
Clarification on chemotherapy regimens and patient preparation was provided.
Interpretation:
The article has been updated to reflect accurate information regarding surgical interventions and treatment protocols.
Limitations:
The correction does not address any potential implications of the inaccuracies on previous findings.
Conclusion:
The original version of the article has been updated to correct errors and clarify treatment protocols.